Market Overview:
The global indocyanine green market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for indocyanine green in various applications such as cardiac, circulatory and micro-circulatory diagnostics, liver function diagnostics, and ophthalmic angiography diagnostics. In addition, the growing awareness about the benefits of indocyanine green is also contributing to the growth of this market.
Product Definition:
A green dye used in angiography to visualize blood vessels.
Pharma Grade:
Indocyanine green is a liquid, odorless compound used as an ingredient in pharmaceuticals and medical products. It's main function is to act as a counter indicator for the presence of oxygen in blood vessels during medical procedures. Indocyanine green has been approved by the U.
Others:
Others are the other ingredients used in Indocyanine Green production. Others mainly consist of excipients and pigments. Others also include preservatives, flavors, sweeteners and colors.
Application Insights:
Indocyanine green is used in various diagnostic applications including cardiac, circulatory and micro-circulatory diagnostics, liver function diagnostics, ophthalmic angiography diagnostics. Cardiac application dominated the overall market with a share of over 40% in 2017 owing to its wide range of applications such as arrhythmia diagnosis and blood flow velocity measurement. Indocyanine green is also used for the detection of heart block which occurs when the electrical impulse cannot be transmitted through the heart muscle effectively. In addition, it is also used for measuring blood flow velocities during angiography procedures which further enhances its use in cardiac imaging studies.
Circulatory and micro-circulatory diagnostics are expected to witness lucrative growth over the forecast period due to increasing demand for noninvasive diagnostic solutions that provide faster results with higher accuracy levels than conventional methods.
Regional Analysis:
Asia Pacific is expected to be the fastest-growing region with a CAGR of XX% over the forecast period. The growth can be attributed to various factors such as increasing COVID-19 positive cases, rising healthcare expenditure, and growing awareness about Indocyanine green usage in different diagnostic applications. In addition, increasing prevalence of cardiac disorders and other diseases is also anticipated to boost market growth in this region during the forecast period. For instance, according to data published by NCBI; around 1 million people die due to cardiovascular diseases every year in China which accounts for 13% of all deaths recorded annually in China’s population of around 1.4 billion people (NCBI).
In 2016, Europe accounted for more than 25% share owing to high demand from countries like Germany.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 6.5% from 2016 to 2021. This is primarily due to the advantages offered by these surgeries over traditional open surgery, such as shorter hospital stays, reduced pain and blood loss, and faster recovery times. Indocyanine green is widely used in minimally invasive procedures such as laparoscopy and arthroscopy owing to its ability to visualize blood vessels and other structures in near-real time.
- Rising prevalence of cancer: According to the World Health Organization (WHO), cancer accounted for 8.8 million deaths worldwide in 2015, making it one of the leading causes of death globally. The incidence of cancer is rising rapidly due to factors such as aging population, changing lifestyles (smoking, unhealthy diet), and environmental pollution. This has led to an increased demand for diagnostic tests and treatments that can improve patient outcomes while reducing costs associated with treatment failures or recurrences thereof . Indocyanine green plays an important role in both diagnosis and treatment of various types of cancers owing its ability detect tumors early on .
Scope Of The Report
Report Attributes
Report Details
Report Title
Indocyanine Green Market Research Report
By Type
Pharma Grade, Others
By Application
Cardiac,Circulatory and Micro-circulatory Diagnostics, Liver Function Diagnostics, Ophthalmic Angiography Diagnostics
By Companies
Diagnostic Green, Akorn, ...
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Indocyanine Green Market Report Segments:
The global Indocyanine Green market is segmented on the basis of:
Types
Pharma Grade, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiac,Circulatory and Micro-circulatory Diagnostics, Liver Function Diagnostics, Ophthalmic Angiography Diagnostics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Diagnostic Green
- Akorn
- ...
Highlights of The Indocyanine Green Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pharma Grade
- Others
- By Application:
- Cardiac,Circulatory and Micro-circulatory Diagnostics
- Liver Function Diagnostics
- Ophthalmic Angiography Diagnostics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Indocyanine Green Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Indocyanine green (ICG) is a dye that is used in medical imaging to create images of organs and tissues. ICG is also used as a marker for cancerous cells.
Some of the major companies in the indocyanine green market are Diagnostic Green, Akorn.
The indocyanine green market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Indocyanine Green Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Indocyanine Green Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Indocyanine Green Market - Supply Chain
4.5. Global Indocyanine Green Market Forecast
4.5.1. Indocyanine Green Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Indocyanine Green Market Size (000 Units) and Y-o-Y Growth
4.5.3. Indocyanine Green Market Absolute $ Opportunity
5. Global Indocyanine Green Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Indocyanine Green Market Size and Volume Forecast by Type
5.3.1. Pharma Grade
5.3.2. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Indocyanine Green Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Indocyanine Green Market Size and Volume Forecast by Application
6.3.1. Cardiac,Circulatory and Micro-circulatory Diagnostics
6.3.2. Liver Function Diagnostics
6.3.3. Ophthalmic Angiography Diagnostics
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Indocyanine Green Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Indocyanine Green Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Indocyanine Green Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Indocyanine Green Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Indocyanine Green Demand Share Forecast, 2019-2029
9. North America Indocyanine Green Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Indocyanine Green Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Indocyanine Green Market Size and Volume Forecast by Application
9.4.1. Cardiac,Circulatory and Micro-circulatory Diagnostics
9.4.2. Liver Function Diagnostics
9.4.3. Ophthalmic Angiography Diagnostics
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Indocyanine Green Market Size and Volume Forecast by Type
9.7.1. Pharma Grade
9.7.2. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Indocyanine Green Demand Share Forecast, 2019-2029
10. Latin America Indocyanine Green Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Indocyanine Green Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Indocyanine Green Market Size and Volume Forecast by Application
10.4.1. Cardiac,Circulatory and Micro-circulatory Diagnostics
10.4.2. Liver Function Diagnostics
10.4.3. Ophthalmic Angiography Diagnostics
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Indocyanine Green Market Size and Volume Forecast by Type
10.7.1. Pharma Grade
10.7.2. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Indocyanine Green Demand Share Forecast, 2019-2029
11. Europe Indocyanine Green Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Indocyanine Green Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Indocyanine Green Market Size and Volume Forecast by Application
11.4.1. Cardiac,Circulatory and Micro-circulatory Diagnostics
11.4.2. Liver Function Diagnostics
11.4.3. Ophthalmic Angiography Diagnostics
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Indocyanine Green Market Size and Volume Forecast by Type
11.7.1. Pharma Grade
11.7.2. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Indocyanine Green Demand Share, 2019-2029
12. Asia Pacific Indocyanine Green Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Indocyanine Green Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Indocyanine Green Market Size and Volume Forecast by Application
12.4.1. Cardiac,Circulatory and Micro-circulatory Diagnostics
12.4.2. Liver Function Diagnostics
12.4.3. Ophthalmic Angiography Diagnostics
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Indocyanine Green Market Size and Volume Forecast by Type
12.7.1. Pharma Grade
12.7.2. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Indocyanine Green Demand Share, 2019-2029
13. Middle East & Africa Indocyanine Green Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Indocyanine Green Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Indocyanine Green Market Size and Volume Forecast by Application
13.4.1. Cardiac,Circulatory and Micro-circulatory Diagnostics
13.4.2. Liver Function Diagnostics
13.4.3. Ophthalmic Angiography Diagnostics
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Indocyanine Green Market Size and Volume Forecast by Type
13.7.1. Pharma Grade
13.7.2. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Indocyanine Green Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Indocyanine Green Market: Market Share Analysis
14.2. Indocyanine Green Distributors and Customers
14.3. Indocyanine Green Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Diagnostic Green
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Akorn
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. ...
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
